News, events, and resources
Sep 18, 2025
Receptor occupancy of antibody drug measured by flow cytometry
Our experts developed a PD-1 receptor occupancy (RO) assay to monitor drug–target interactions and support pharmacodynamic evaluation in ...
Sep 17, 2025
Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology
Dr. Lorin K. Roskos joins CBS as CSO & Head of Quantitative Clinical Pharmacology (QCP), bringing 30+ years of R&D expertise to ...
Sep 16, 2025
A LC-MS/MS Method for Oligonucleotide PK Bioanalysis
In this case study our experts developed an LC-MS/MS method for oligonucleotide pharmacokinetic (PK) analysis in a Phase 1 clinical studies.
Sep 16, 2025
Immunophenotyping to identify peripheral lymphocyte subsets
Discover how our experts developed FACS-based immunophenotyping method to monitor T and NK cell populations in solid tumor treatment ...
Sep 16, 2025
Sample Pretreatment Approaches to Improve Drug Tolerance in ADA Assay
In this case study our experts developed an ADA assay for a prodrug where traditional acid dissociation alone could not meet tolerance ...
Receptor occupancy of antibody drug measured by flow cytometry
Our experts developed a PD-1 receptor occupancy (RO) assay to monitor drug–target interactions and support pharmacodynamic evaluation in ...
A LC-MS/MS Method for Oligonucleotide PK Bioanalysis
In this case study our experts developed an LC-MS/MS method for oligonucleotide pharmacokinetic (PK) analysis in a Phase 1 clinical studies.
Immunophenotyping to identify peripheral lymphocyte subsets
Discover how our experts developed FACS-based immunophenotyping method to monitor T and NK cell populations in solid tumor treatment ...
Sample Pretreatment Approaches to Improve Drug Tolerance in ADA Assay
In this case study our experts developed an ADA assay for a prodrug where traditional acid dissociation alone could not meet tolerance ...
Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology
Dr. Lorin K. Roskos joins CBS as CSO & Head of Quantitative Clinical Pharmacology (QCP), bringing 30+ years of R&D expertise to ...